Association between frequent CpG island methylation and HER2 amplification in human breast cancers

被引：0
|
作者：
Terada, Kotoe
Okochi-Takada, Eriko
Akashi-Tanaka, Sadako
Miyamoto, Kazuaki
Taniyama, Kiyomi
Tsuda, Hitoshi
Asada, Kiyoshi
Kaminishi, Michio
Ushijima, Toshikazu
机构：
[1] Natl Canc Ctr, Res Inst, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Kure Med Ctr, Natl Hosp Org, Kure, Japan
[4] Univ Tokyo, Sch Med, Tokyo 113, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-165
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [32] Phenotypes of Breast Cancers Heterogeneous for HER2 Gene Amplification: Looking for Biologically Relevant Thresholds
    Kilgore, M. R.
    Kranseler, J. S.
    Dintzis, S. M.
    Schmidt, R. A.
    Swanson, P. E.
    Rendi, M. H.
    Linden, H. M.
    Allison, K. H.
    MODERN PATHOLOGY, 2013, 26 : 49A - 50A
  • [33] Characterisation of the Genetic Heterogeneity of Invasive Breast Cancers with Heterogeneous HER2 Overexpression and Gene Amplification
    Ng, C. K. Y.
    Gauthier, A.
    Wilkerson, P. M.
    Lambros, M. B.
    Arnoud, L.
    Lacroix-Triki, M.
    Penault-Llorca, F.
    Baranzelli, M. C.
    Sastre-Garau, X.
    Lord, C. J.
    Zvelebil, M.
    Mitsopoulos, C.
    Ashworth, A.
    Natrajan, R.
    Weigelt, B.
    Delattre, O.
    Cottu, P.
    Reis-Filho, J. S.
    Vincent-Salomon, A.
    MODERN PATHOLOGY, 2013, 26 : 58A - 58A
  • [34] Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae
    Enomoto, Shotaro
    Maekita, Takao
    Tsukamoto, Tetsuya
    Nakajima, Takeshi
    Nakazawa, Kazuyuki
    Tatematsu, Masae
    Ichinose, Masao
    Ushijima, Toshikazu
    CANCER SCIENCE, 2007, 98 (12) : 1853 - 1861
  • [35] Characterisation of the Genetic Heterogeneity of Invasive Breast Cancers with Heterogeneous HER2 Overexpression and Gene Amplification
    Ng, C. K. Y.
    Gauthier, A.
    Wilkerson, P. M.
    Lambros, M. B.
    Arnoud, L.
    Lacroix-Triki, M.
    Penault-Llorca, F.
    Baranzelli, M. C.
    Sastre-Garau, X.
    Lord, C. J.
    Zvelebil, M.
    Mitsopoulos, C.
    Ashworth, A.
    Natrajan, R.
    Weigelt, B.
    Delattre, O.
    Cottu, P.
    Reis-Filho, J. S.
    Vincent-Salomon, A.
    LABORATORY INVESTIGATION, 2013, 93 : 58A - 58A
  • [36] Phenotypes of Breast Cancers Heterogeneous for HER2 Gene Amplification: Looking for Biologically Relevant Thresholds
    Kilgore, M. R.
    Kranseler, J. S.
    Dintzis, S. M.
    Schmidt, R. A.
    Swanson, P. E.
    Rendi, M. H.
    Linden, H. M.
    Allison, K. H.
    LABORATORY INVESTIGATION, 2013, 93 : 49A - 50A
  • [37] Observer prediction of HER2 amplification in HercepTest 2+breast cancers as a potential audit instrument
    Going, James J.
    HISTOPATHOLOGY, 2011, 59 (02) : 333 - 335
  • [38] Automation of FISH analysis to detect HER2 amplification in human breast cancer
    Wragg, Christopher
    Roberts, E.
    Ibrahim, N.
    Davies, T.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 : S27 - S27
  • [39] Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation. 8067
    Li, Bob T.
    Ross, Dara S.
    Chaft, Jamie E.
    Hsu, Meier
    Kako, Severine
    Aisner, Dara L.
    Kris, Mark G.
    Varella-Garcia, Marileila
    Arcila, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] HER2 downstream signaling events differ between breast and ovarian cancers
    Nature Clinical Practice Oncology, 2007, 4 (5): : 266 - 267
12345